Published Erratum
doi: 10.1038/s41586-022-05226-7.
Author Correction: PHGDH heterogeneity potentiates cancer cell dissemination and metastasis
Matteo Rossi #
1
2
, Patricia Altea-Manzano #
1
2
, Margherita Demicco
1
2
, Ginevra Doglioni
1
2
, Laura Bornes
3
, Marina Fukano
4
5
6
, Anke Vandekeere
1
2
, Alejandro M Cuadros
1
2
, Juan Fernández-García
1
2
, Carla Riera-Domingo
7
8
, Cristina Jauset
9
, Mélanie Planque
1
2
, H Furkan Alkan
1
2
, David Nittner
10
11
, Dongmei Zuo
6
, Lindsay A Broadfield
1
2
, Sweta Parik
1
2
, Antonino Alejandro Pane
1
2
, Francesca Rizzollo
1
2
, Gianmarco Rinaldi
1
2
, Tao Zhang
12
, Shao Thing Teoh
13
, Arin B Aurora
14
, Panagiotis Karras
11
15
, Ines Vermeire
1
2
, Dorien Broekaert
1
2
, Joke Van Elsen
1
2
, Maximilian M L Knott
16
, Martin F Orth
16
, Sofie Demeyer
17
, Guy Eelen
18
19
, Lacey E Dobrolecki
20
, Ayse Bassez
21
22
, Thomas Van Brussel
21
22
, Karl Sotlar
23
, Michael T Lewis
20
, Harald Bartsch
24
, Manfred Wuhrer
12
, Peter van Veelen
12
, Peter Carmeliet
18
19
25
26
, Jan Cools
17
, Sean J Morrison
14
27
, Jean-Christophe Marine
11
15
, Diether Lambrechts
21
22
, Massimiliano Mazzone
7
8
28
, Gregory J Hannon
9
, Sophia Y Lunt
13
29
, Thomas G P Grünewald
16
30
31
32
, Morag Park
5
6
, Jacco van Rheenen
3
, Sarah-Maria Fendt
33
34
Affiliations
Affiliations
- 1 Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium.
- 2 Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
- 3 Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
- 4 Institute for Research in Immunology and Cancer (IRIC), University of Montreal, Montreal, Quebec, Canada.
- 5 Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.
- 6 Rosalind & Morris Goodman Cancer Institute (GCI), McGill University, Montreal, Quebec, Canada.
- 7 Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology (CCB), VIB, Leuven, Belgium.
- 8 Laboratory of Tumor Inflammation and Angiogenesis, Department of Oncology, KU Leuven, Leuven, Belgium.
- 9 Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
- 10 Histopathology Expertise Center, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
- 11 Department of Oncology, KU Leuven, Leuven, Belgium.
- 12 Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.
- 13 Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA.
- 14 Children's Research Institute and Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- 15 Laboratory of Molecular Cancer Biology, VIB Center for Cancer Biology, Leuven, Belgium.
- 16 Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany.
- 17 Laboratory for Molecular Biology of Leukemia, VIB-KU Leuven, Leuven, Belgium.
- 18 Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium.
- 19 Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, VIB, Leuven, Belgium.
- 20 StemMed, Houston, TX, USA.
- 21 Laboratory for Translational Genetics, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium.
- 22 Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.
- 23 Institute of Pathology, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria.
- 24 Institute of Pathology, Ludwig Maximilians University, Munich, Germany.
- 25 Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates.
- 26 Laboratory of Angiogenesis and Vascular Heterogeneity, Department of Biomedicine, Aarhus University, Aarhus, Denmark.
- 27 Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- 28 Department of Molecular Biotechnology and Health Science, Molecular Biotechnology Centre, University of Torino, Torino, Italy.
- 29 Department of Chemical Engineering and Materials Science, Michigan State University, East Lansing, MI, USA.
- 30 Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
- 31 Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
- 32 Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
- 33 Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium. sarah-maria.fendt@kuleuven.be.
- 34 Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium. sarah-maria.fendt@kuleuven.be.
# Contributed equally.
- PMID: 36042336
- PMCID: PMC9904429
- DOI: 10.1038/s41586-022-05226-7
Item in Clipboard
Published Erratum
Author Correction: PHGDH heterogeneity potentiates cancer cell dissemination and metastasis
Matteo Rossi et al.
Nature.
2022 Sep.
Display options
Format
doi: 10.1038/s41586-022-05226-7.
Authors
Matteo Rossi #
1
2
, Patricia Altea-Manzano #
1
2
, Margherita Demicco
1
2
, Ginevra Doglioni
1
2
, Laura Bornes
3
, Marina Fukano
4
5
6
, Anke Vandekeere
1
2
, Alejandro M Cuadros
1
2
, Juan Fernández-García
1
2
, Carla Riera-Domingo
7
8
, Cristina Jauset
9
, Mélanie Planque
1
2
, H Furkan Alkan
1
2
, David Nittner
10
11
, Dongmei Zuo
6
, Lindsay A Broadfield
1
2
, Sweta Parik
1
2
, Antonino Alejandro Pane
1
2
, Francesca Rizzollo
1
2
, Gianmarco Rinaldi
1
2
, Tao Zhang
12
, Shao Thing Teoh
13
, Arin B Aurora
14
, Panagiotis Karras
11
15
, Ines Vermeire
1
2
, Dorien Broekaert
1
2
, Joke Van Elsen
1
2
, Maximilian M L Knott
16
, Martin F Orth
16
, Sofie Demeyer
17
, Guy Eelen
18
19
, Lacey E Dobrolecki
20
, Ayse Bassez
21
22
, Thomas Van Brussel
21
22
, Karl Sotlar
23
, Michael T Lewis
20
, Harald Bartsch
24
, Manfred Wuhrer
12
, Peter van Veelen
12
, Peter Carmeliet
18
19
25
26
, Jan Cools
17
, Sean J Morrison
14
27
, Jean-Christophe Marine
11
15
, Diether Lambrechts
21
22
, Massimiliano Mazzone
7
8
28
, Gregory J Hannon
9
, Sophia Y Lunt
13
29
, Thomas G P Grünewald
16
30
31
32
, Morag Park
5
6
, Jacco van Rheenen
3
, Sarah-Maria Fendt
33
34
Affiliations
- 1 Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium.
- 2 Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
- 3 Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
- 4 Institute for Research in Immunology and Cancer (IRIC), University of Montreal, Montreal, Quebec, Canada.
- 5 Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.
- 6 Rosalind & Morris Goodman Cancer Institute (GCI), McGill University, Montreal, Quebec, Canada.
- 7 Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology (CCB), VIB, Leuven, Belgium.
- 8 Laboratory of Tumor Inflammation and Angiogenesis, Department of Oncology, KU Leuven, Leuven, Belgium.
- 9 Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
- 10 Histopathology Expertise Center, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
- 11 Department of Oncology, KU Leuven, Leuven, Belgium.
- 12 Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands.
- 13 Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA.
- 14 Children's Research Institute and Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- 15 Laboratory of Molecular Cancer Biology, VIB Center for Cancer Biology, Leuven, Belgium.
- 16 Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany.
- 17 Laboratory for Molecular Biology of Leukemia, VIB-KU Leuven, Leuven, Belgium.
- 18 Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium.
- 19 Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, VIB, Leuven, Belgium.
- 20 StemMed, Houston, TX, USA.
- 21 Laboratory for Translational Genetics, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium.
- 22 Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.
- 23 Institute of Pathology, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria.
- 24 Institute of Pathology, Ludwig Maximilians University, Munich, Germany.
- 25 Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates.
- 26 Laboratory of Angiogenesis and Vascular Heterogeneity, Department of Biomedicine, Aarhus University, Aarhus, Denmark.
- 27 Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- 28 Department of Molecular Biotechnology and Health Science, Molecular Biotechnology Centre, University of Torino, Torino, Italy.
- 29 Department of Chemical Engineering and Materials Science, Michigan State University, East Lansing, MI, USA.
- 30 Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
- 31 Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
- 32 Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
- 33 Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium. sarah-maria.fendt@kuleuven.be.
- 34 Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium. sarah-maria.fendt@kuleuven.be.
# Contributed equally.
- PMID: 36042336
- PMCID: PMC9904429
- DOI: 10.1038/s41586-022-05226-7
Item in Clipboard
Display options
Format
No abstract available
Erratum for
-
PHGDH heterogeneity potentiates cancer cell dissemination and metastasis.Rossi M, Altea-Manzano P, Demicco M, Doglioni G, Bornes L, Fukano M, Vandekeere A, Cuadros AM, Fernández-García J, Riera-Domingo C, Jauset C, Planque M, Alkan HF, Nittner D, Zuo D, Broadfield LA, Parik S, Pane AA, Rizzollo F, Rinaldi G, Zhang T, Teoh ST, Aurora AB, Karras P, Vermeire I, Broekaert D, Elsen JV, Knott MML, Orth MF, Demeyer S, Eelen G, Dobrolecki LE, Bassez A, Brussel TV, Sotlar K, Lewis MT, Bartsch H, Wuhrer M, Veelen PV, Carmeliet P, Cools J, Morrison SJ, Marine JC, Lambrechts D, Mazzone M, Hannon GJ, Lunt SY, Grünewald TGP, Park M, Rheenen JV, Fendt SM. Rossi M, et al. Nature. 2022 May;605(7911):747-753. doi: 10.1038/s41586-022-04758-2. Epub 2022 May 18. Nature. 2022. PMID: 35585241 Free PMC article.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
